Business Standard

Concord Biotech Share Price

Know More
BSENSE

1,701.35-8.65 (-0.51%)

16th Jul 2024

1,701.85-11.40 (-0.67%)

16th Jul 2024

BSE : 543960

NSE : CONCORDBIO

Sector : Health care

ISIN Code : INE338H01029

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 16-Jul-2024

Market Cap (₹ Cr)

17,796

Traded Value (₹ Cr)

0.44

Volume (Shares)

2,572

Face Value (₹)

1

52-Week High (₹)

1,793.50

52-Week High Date

10-Jul-2024

52-Week Low (₹)

900.00

52-Week Low Date

18-Aug-2023

All Time High (₹)

1,793.50

All Time High Date

10-Jul-2024

All Time Low (₹)

900.00

All Time Low Date

18-Aug-2023

Concord Biotech Ltd

Concord Biotech Ltd was originally incorporated as `Servomed Pharmaceuticals Private Limited' at Ahmedabad Gujarat as a Private Limited Company dated November 23 1984 issued by the Registrar of Companies. Thereafter name of the Company was changed to `Concord Biotech Limited' dated February 16 2001 which became a Public Company and a fresh Certificate of Incorporation dated November 7 2001 was issued by the RoC.The Company is an India-based biopharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immuno-suppressants and oncology in terms of market share based on volume in supplying to over 70 countries including regulated markets such as t...
Read More

Concord Biotech Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

17,801

EPS - TTM (₹) [C]

28.45

P/E Ratio (X) [C]

59.82

Face Value (₹) 1
Latest Dividend (%)875.00
Latest Dividend Date 21-Jun-2024
Dividend Yield (%) 0.51
Book Value Share (₹) [C]145.93
P/B Ratio (₹) [C]11.66

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
HSBC Small Cap Fund (G) 132.28 8,53,962 0.81
HSBC Small Cap Fund (IDCW) 132.28 8,53,962 0.81
HSBC Small Cap Fund - Direct (G) 132.28 8,53,962 0.81
HSBC Small Cap Fund - Direct (IDCW) 132.28 8,53,962 0.81
DSP Healthcare Fund (G) 96.75 6,24,569 3.90
DSP Healthcare Fund (IDCW) 96.75 6,24,569 3.90
DSP Healthcare Fund - Direct (G) 96.75 6,24,569 3.90
DSP Healthcare Fund - Direct (IDCW) 96.75 6,24,569 3.90
Invesco India Multicap Fund (G) 64.92 4,19,067 1.79
Invesco India Multicap Fund (IDCW) 64.92 4,19,067 1.79

Load more

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

1,679.00

1,738.95

Week Low/High (₹)

1,666.80

1,799.00

Month Low/High (₹)

1,441.40

1,799.00

Year Low/High (₹)

900.05

1,799.00

All time Low/High (₹)

900.00

1,799.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week0.32%0.31%0.450.74%
1 Month11.16%11.20%4.844.89%
3 Month11.14%11.28%10.6611.13%
6 Month18.80%18.73%10.3811.71%
1 Year%%22.1925.80%
3 Year%%51.8954.57%

Company Info

Company Information

Chairman & Managing Director : SUDHIR JAIRAM VAID

Joint Managing Director & CEO : ANKUR VAID

Non Executive Director : Ravi Kapoor

Nominee : Rajiv Agarwal

Independent Director : BHARTI KHANNA

Independent Director : Amitabh Thakore

Independent Director : Arvind Agarwal

Independent Director : Jayaram Easwaran

Independent Director : Mandayam Chakravarthy Sriraman

Assistant VP (Finance) & CS : S Prakash

Registered Office: 1482-86 Trasad Road, Dholka,Ahmedabad,Gujarat-382225 Ph: 91-079-68138700

Email:complianceofficer@concordbiotech.com

URL:http://www.concordbiotech.com

FAQs about Concord Biotech Ltd

1. What's the Concord Biotech Ltd share price today?
Concord Biotech Ltd share price was Rs 1,701.35 at close on 16th Jul 2024. Concord Biotech Ltd share price was down by 0.51% from the previous closing price of Rs 1,710.00. Concord Biotech Ltd share price trend:

  • Last 1 Month: Concord Biotech Ltd share price moved up by 11.16% on BSE
  • Last 3 Months: Concord Biotech Ltd share price moved up by 11.14% on BSE
  • Last 12 Months: Concord Biotech Ltd share price moved up by % on BSE
  • Last 3 Years: Concord Biotech Ltd price moved up by % on BSE


2. How can I quickly analyse the performance of the Concord Biotech Ltd stock?
The performance of the Concord Biotech Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 59.82
  • Price to book value ratio is 11.66
  • Dividend yield of 0.51
  • The EPS (trailing 12 months) of the Concord Biotech Ltd stock is Rs 28.45


3. What is the market cap of Concord Biotech Ltd?
Concord Biotech Ltd has a market capitalisation of Rs 17,796 crore.


4. What is Concord Biotech Ltd's 52-week high/low share price?
The Concord Biotech Ltd’s 52-week high share price is Rs 1,793.50 and 52-week low share price is Rs 900.00.


5. Is the Concord Biotech Ltd profitable?
On a consolidated basis, Concord Biotech Ltd reported a profit of Rs 97.21 crore on a total income of Rs 329.78 crore for the quarter ended 2024. For the year ended Mar 2024, Concord Biotech Ltd had posted a profit of Rs 95.02 crore on a total income of Rs 329.78 crore.


6. Which are Concord Biotech Ltd’s peers in the Health care sector?
Concord Biotech Ltd’s top 5 peers in the Health care sector are Suven Pharma, Alembic Pharma, Piramal Pharma, Concord Biotech, Astrazeneca Phar, Sanofi India, ERIS Lifescience.


7. Who owns how much in Concord Biotech Ltd?
Key changes to the Concord Biotech Ltd shareholding are as follows:

  • Promoter holding in Concord Biotech Ltd has gone up to 44.08 per cent as of Jun 2024 from 44.08 per cent as of Sep 2023.